LENZ Therapeutics Inc. (LENZ)
25.30
-0.95 (-3.62%)
At close: Jan 29, 2025, 3:59 PM
25.18
-0.47%
After-hours Jan 29, 2025, 04:00 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Cash & Equivalents | 185.86M | 47.73M | 376.98M | 19.82M | 6.00K |
| Short-Term Investments | n/a | 220.50M | n/a | n/a | n/a |
| Long-Term Investments | 114.00K | 17.04M | n/a | n/a | n/a |
| Other Long-Term Assets | n/a | 1.29M | 2.17M | -1 | n/a |
| Receivables | n/a | n/a | n/a | n/a | n/a |
| Inventory | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 2.16M | 2.20M | 4.76M | 1.29M | n/a |
| Total Current Assets | 188.02M | 275.37M | 381.74M | 21.10M | 6.00K |
| Property-Plant & Equipment | 321.00K | 28.21M | 18.08M | 1.46M | n/a |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 435.00K | 46.54M | 20.25M | 1.46M | n/a |
| Total Assets | 188.46M | 321.90M | 401.99M | 22.56M | 6.00K |
| Account Payables | 250.00K | 2.26M | 460.00K | 630.00K | n/a |
| Deferred Revenue | n/a | n/a | n/a | n/a | n/a |
| Short-Term Debt | 285.00K | 103.00K | n/a | n/a | 2.21M |
| Other Current Liabilities | 4.26M | 10.33M | 11.68M | 31.42M | 19.00K |
| Total Current Liabilities | 4.80M | 13.04M | 12.14M | 32.05M | 2.22M |
| Long-Term Debt | 77.00K | 147.00K | n/a | n/a | n/a |
| Other Long-Term Liabilities | -1 | 12.42M | 31.30M | 316.00K | n/a |
| Total Long-Term Liabilities | 77.00K | 12.57M | 25.40M | 316.00K | n/a |
| Total Liabilities | 4.87M | 25.61M | 12.14M | 32.36M | 2.22M |
| Total Debt | 362.00K | 5.79M | n/a | n/a | 2.21M |
| Common Stock | 1K | 1K | 1K | n/a | n/a |
| Retained Earnings | -367.05M | -242.40M | -141.35M | -70.59M | -2.22M |
| Comprehensive Income | n/a | -1.05M | -999 | n/a | n/a |
| Shareholders Equity | 183.58M | 296.29M | 389.84M | -9.80M | -2.22M |
| Total Investments | 114.00K | 237.54M | n/a | n/a | n/a |